← Leaderboards
Jesse D Roberts
Massachusetts General Hospital
$5,898,176
Attributed
$5,898,176
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $442.4K · FY2005–19$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$5,898,176 · 5
By mechanism
R01$4,823,045 · 3
K08$649,755 · 1
R56$425,376 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Fumito Ichinose$9,083,343
- Dmitriy Atochin$1,769,750
- Kenneth D Bloch$14,282,889
- Mauro Longoni$1,999,504
- David N Louis$11,615,613
Others in their field
Top investigators on “Nitric Oxide”
- Solomon H Snyder · Johns Hopkins University$33,003,131
- Jay Louis Zweier · Ohio State University$27,671,715
- Stuart A Lipton · Burnham Institute For Medical Research$26,301,120
- Serpil C. Erzurum · Cleveland Clinic Lerner Com-Cwru$24,661,240
- Jonathan S. Stamler · Case Western Reserve University$24,571,968
- William C. Sessa · Yale University$21,022,028
Research focus
Nitric OxideCell ProliferationPreventLung InjurySignal TransductionLungInjuredChildhoodCell Differentiation ProcessVascular DiseasesBlood VesselsPeripheralEnzyme ActivityLeadBaseInhibitor/AntagonistGene ExpressionCyclic GmpPhenotypePulmonary Artery StructureCessation Of LifeLung DevelopmentBreathingAntibodies
Grant awards (18)
TGFB AND PULMONARY ALDEHYDES IN NEWBORN LUNG INJURY$425,376
R56 · FY2019 · HL · contact PI
TGFB and Nitric Oxide Signaling in Pediatric Pulmonary Vascular Disease$432,030
R01 · FY2018 · HL · contact PI
TGFB and Nitric Oxide Signaling in Pediatric Pulmonary Vascular Disease$431,868
R01 · FY2017 · HL · contact PI
TGFB and Nitric Oxide Signaling in Pediatric Pulmonary Vascular Disease$434,825
R01 · FY2016 · HL · contact PI
TGFB and Nitric Oxide Signaling in Pediatric Pulmonary Vascular Disease$434,987
R01 · FY2015 · HL · contact PI
Mechanisms regulating PKGI proteolysis and modulation of pulmonary SMC phenotype$416,417
R01 · FY2013 · HL · contact PI
Mechanisms regulating PKGI proteolysis and modulation of pulmonary SMC phenotype$437,955
R01 · FY2012 · HL · contact PI
Mechanisms regulating PKGI proteolysis and modulation of pulmonary SMC phenotype$442,381
R01 · FY2011 · HL · contact PI
Mechanisms regulating PKGI proteolysis and modulation of pulmonary SMC phenotype$438,535
R01 · FY2010 · HL · contact PI
Mechanisms of PKG-induced PASMC Differentiation$331,507
R01 · FY2008 · HL · contact PI
Mechanisms of PKG-induced PASMC Differentiation$331,507
R01 · FY2007 · HL · contact PI
Mechanisms of PKG-induced PASMC Differentiation$341,408
R01 · FY2006 · HL · contact PI
Mechanisms of PKG-induced PASMC Differentiation$349,625
R01 · FY2005 · HL
ANTIMITOGENIC MECHANISMS OF PKG IN VASCULAR SM CELLS$129,951
K08 · FY2004 · HL
ANTIMITOGENIC MECHANISMS OF PKG IN VASCULAR SM CELLS$129,951
K08 · FY2003 · HL
ANTIMITOGENIC MECHANISMS OF PKG IN VASCULAR SM CELLS$129,951
K08 · FY2002 · HL
ANTIMITOGENIC MECHANISMS OF PKG IN VASCULAR SM CELLS$129,951
K08 · FY2001 · HL
ANTIMITOGENIC MECHANISMS OF PKG IN VASCULAR SM CELLS$129,951
K08 · FY2000 · HL